Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
1975606
Reference Type
Journal Article
Title
Immunohistochemical distribution of cAMP- and cGMP-phosphodiesterase (PDE) isoenzymes in the human prostate
Author(s)
Uckert, S; Oelke, M; Stief, CG; Andersson, KE; Jonas, U; Hedlund, P
Year
2006
Is Peer Reviewed?
Yes
Journal
European Urology
ISSN:
0302-2838
Volume
49
Issue
4
Page Numbers
740-745
Language
English
PMID
16460876
DOI
10.1016/j.eururo.2005.12.050
URL
http://dx.doi.org/10.1016/j.eururo.2005.12.050
Exit
Abstract
OBJECTIVES:
With the introduction of sildenafil citrate (Viagra), the concept of phosphodiesterase (PDE) inhibition has gained tremendous interest in the field of urology. Cyclic nucleotide second messengers cGMP and cAMP have been assumed to be involved in the control of the normal function of the prostate. The aim of the present study was to evaluate by means of immunohistochemistry the expression and distribution of some cAMP- and cGMP-PDE isoenzymes in the prostate.
MATERIAL & METHODS:
Cryostat sections (10 microM) of formaldehyde-fixated tissue segments excised from the transition zone of human prostates were incubated with primary antibodies directed against the PDE isoenzymes 3, 4, 5, and 11. Then, sections were exposed to either fluorescein isothiocyanate- (FITC) or Texas Red- (TR) labeled secondary antibodies and visualization was commenced by means of laser fluorescence microscopy.
RESULTS:
TR-immunofluorescence indicating the presence of PDE4 (cAMP-PDE) was abundantly observed in the fibromuscular stroma as well as in glandular structures of the transition zone. In contrast to the distribution of PDE4, immunoactivity indicating PDE5 (cGMP-PDE) and 11 (dual substrate PDE) was mainly observed in glandular and subglandular areas. No immunostaining for PDE3 (cGMP-inhibited PDE) was detected.
CONCLUSION:
Our results confirm the presence of PDE isoenzymes 4, 5 and 11 in the transition zone of the human prostate and present evidence that these isoenzymes are not evenly distributed. These findings are in support of the hypothesis that there might be a rationale for the use of PDE inhibitors in the pharmacotherapy of BPH and LUTS.
Keywords
3',5'-Cyclic-AMP Phosphodiesterases/ metabolism; 3',5'-Cyclic-GMP Phosphodiesterases/ metabolism; Fluorescein; Immunohistochemistry; Isoenzymes/ metabolism; Microscopy, Confocal; Microscopy, Fluorescence; Prostate/ enzymology; Xanthenes
Tags
IRIS
•
Formaldehyde [archived]
Reproductive and Developmental Effects
Screened
Title/abstract
Methodology/therapeutics
Inflammation/Reactive Oxygen Species
PubMed
Screened by Title/Abstract
Related to Methodology or Process
Retroactive RIS import
2014
HERO_Formaldehyde_InflammationReactiveOxygenSpecies_pid_31_uid_5713Sorting091214
HERO_Formaldehyde_InflammationReactiveOxygenSpecies_pid_31_uid_5713
Screened (Title/Abstract)
Related to Methodology or Process
2015
FA DevRepro 072115
Methodology/Therapeutics-Population Criteria
•
IRIS Formaldehyde (Inhalation) [Final 2024]
Literature Indexing
PubMed
Literature Identification
Reproductive and Developmental Effects
Excluded
Inflammation and Immune-Related Mechanistic Studies
Excluded
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity